Oral inoculation with Type III secretion mutants of Yersinia pseudotuberculosis provides protection from oral, intraperitoneal, or intranasal challenge with virulent Yersinia

Vaccine

Volumn 25, Issue 8, 2007, Pages 1526-1533

  Balada Llasat, Joan Miquel ^a   Panilaitis, Bruce ^b   Kaplan, David ^b   Mecsas, Joan ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Tufts University   (United States)

Author keywords

Live attenuated; Type III secretion system; Yersinia

Indexed keywords

BACTERIAL VACCINE; LIVE VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; FEMALE; INOCULATION; MESENTERY LYMPH NODE; MORBIDITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; TYPE III SECRETION SYSTEM; YERSINIA PSEUDOTUBERCULOSIS; YERSINIOSIS;

ADMINISTRATION, ORAL; ANIMALS; BACTERIAL VACCINES; FEMALE; MICE; MICE, INBRED BALB C; MUTATION; VACCINES, ATTENUATED; YERSINIA PSEUDOTUBERCULOSIS; YERSINIA PSEUDOTUBERCULOSIS INFECTIONS;

EID: 33846035681     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.10.016     Document Type: Article

References (34)

1. Cover T.L., and Aber R.C. Yersinia enterocolitica. N Engl J Med 321 1 (1989) 16-24
2. Nikolova S., Tzvetkov Y., Najdenski H., and Vesselinova A. Isolation of pathogenic yersiniae from wild animals in Bulgaria. J Vet Med B: Infect Dis Vet Public Health 48 3 (2001) 203-209
3. Fukushima H. Susceptibility of wild mice to Yersinia pseudotuberculosis and Yersinia enterocolitica. Zentralbl Bakteriol 275 4 (1991) 530-540
4. Voskressenskaya E., Leclercq A., Tseneva G., and Carniel E. Evaluation of ribotyping as a tool for molecular typing of Yersinia pseudotuberculosis strains of worldwide origin. J Clin Microbiol 43 12 (2005) 6155-6160
5. Achtman M., Zurth K., Morelli G., Torrea G., Guiyoule A., and Carniel E. Yersinia pestis, the cause of plague, is a recently emerged clone of Yersinia pseudotuberculosis. Proc Natl Acad Sci USA 96 24 (1999) 14043-14048
6. Perry R.D., and Fetherston J.D. Yersinia pestis-etiologic agent of plague. Clin Microbiol Rev 10 1 (1997) 35-66
7. Josko D. Yersinia pestis: still a plague in the 21st century. Clin Lab Sci 17 1 (2004) 25-29
8. Fukushima H., Hao Q., Wu K., Hu X., Chen J., Guo Z., et al. Yersinia enterocolitica O9 as a possible barrier against Y. pestis in natural plague foci in Ningxia, China. Curr Microbiol 42 1 (2001) 1-7
9. Simonet M., Berche P., Mazigh D., and Veron M. Protection against Yersinia infection induced by non-virulence-plasmid-encoded antigens. J Med Microbiol 20 2 (1985) 225-231
10. Taylor V.L., Titball R.W., and Oyston P.C. Oral immunization with a dam mutant of Yersinia pseudotuberculosis protects against plague. Microbiology 151 Pt 6 (2005) 1919-1926
11. Cornelis G.R. The Yersinia Ysc-Yop virulence apparatus. Int J Med Microbiol 291 6-7 (2002) 455-462
12. Balada-Llasat J.M., and Mecsas J. Yersinia has a tropism for B and T cell zones of lymph nodes that is independent of the Type III secretion system. PLoS Pathog 2 9 (2006)
13. Logsdon L.K., and Mecsas J. Requirement of the Yersinia pseudotuberculosis effectors YopH and YopE in colonization and persistence in intestinal and lymph tissues. Infect Immun 71 8 (2003) 4595-4607
14. Pujol C., and Bliska J.B. The ability to replicate in macrophages is conserved between Yersinia pestis and Yersinia pseudotuberculosis. Infect Immun 71 10 (2003) 5892-5899
15. Portnoy D.A., Wolf-Watz H., Bolin I., Beeder A.B., and Falkow S. Characterization of common virulence plasmids in Yersinia species and their role in the expression of outer membrane proteins. Infect Immun 43 1 (1984) 108-114
16. Hava D.L., and Camilli A. Large-scale identification of serotype 4 Streptococcus pneumoniae virulence factors. Mol Microbiol 45 5 (2002) 1389-1406
17. Mecsas J., Bilis I., and Falkow S. Identification of attenuated Yersinia pseudotuberculosis strains and characterization of an orogastric infection in BALB/c mice on day 5 postinfection by signature-tagged mutagenesis. Infect Immun 69 5 (2001) 2779-2787
18. China B., Sory M.P., N'Guyen B., De Bruyere M., and Cornelis G.R. Role of the YadA protein in prevention of opsonization of Yersinia enterocolitica by C3b molecules. Infect Immun 61 8 (1993) 3129-3136
19. Pilz D., Vocke T., Heesemann J., and Brade V. Mechanism of YadA-mediated serum resistance of Yersinia enterocolitica serotype O3. Infect Immun 60 1 (1992) 189-195
20. Monack D.M., Mecsas J., Bouley D., and Falkow S. Yersinia-induced apoptosis in vivo aids in the establishment of a systemic infection of mice. J Exp Med 188 11 (1998) 2127-2137
21. Fukushima H., Sato T., Nagasako R., and Takeda I. Acute mesenteric lymphadenitis due to Yersinia pseudotuberculosis lacking a virulence plasmid. J Clin Microbiol 29 6 (1991) 1271-1275
22. Julio S.M., Heithoff D.M., Provenzano D., Klose K.E., Sinsheimer R.L., Low D.A., et al. DNA adenine methylase is essential for viability and plays a role in the pathogenesis of Yersinia pseudotuberculosis and Vibrio cholerae. Infect Immun 69 12 (2001) 7610-7615
23. Williamson E.D., Flick-Smith H.C., Lebutt C., Rowland C.A., Jones S.M., Waters E.L., et al. Human immune response to a plague vaccine comprising recombinant F1 and V antigens. Infect Immun 73 6 (2005) 3598-3608
24. Heath D.G., Anderson Jr. J.W., Mauro J.M., Welkos S.L., Andrews G.P., and Adamovicz J. Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine. Vaccine 16 11-12 (1998) 1131-1137
25. Williamson E.D., Vesey P.M., Gilhespy K.J., Eley S.M., Green M., and Titball R.W. An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model. Clin Exp Immunol 116 1 (1999) 107-114
26. Williamson E.D., Eley S.M., Stagg A.J., Green M., Russell P., and Titball R.W. A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague. Vaccine 15 10 (1997) 1079-1084
27. Jones S.M., Griffin K.F., Hodgson I., and Williamson E.D. Protective efficacy of a fully recombinant plague vaccine in the guinea pig. Vaccine 21 25-26 (2003) 3912-3918
28. Friedlander A.M., Welkos S.L., Worsham P.L., Andrews G.P., Heath D.G., Anderson Jr. G.W., et al. Relationship between virulence and immunity as revealed in recent studies of the F1 capsule of Yersinia pestis. Clin Infect Dis 21 Suppl 2 (1995) S178-S181
29. Roggenkamp A., Geiger A.M., Leitritz L., Kessler A., and Heesemann J. Passive immunity to infection with Yersinia spp. mediated by anti-recombinant V antigen is dependent on polymorphism of V antigen. Infect Immun 65 2 (1997) 446-451
30. Matson J.S., Durick K.A., Bradley D.S., and Nilles M.L. Immunization of mice with YscF provides protection from Yersinia pestis infections. BMC Microbiol 5 1 (2005) 38
31. Swietnicki W., Powell B.S., and Goodin J. Yersinia pestis Yop secretion protein F: purification, characterization, and protective efficacy against bubonic plague. Protein Expr Purif 42 1 (2005) 166-172
32. Andrews G.P., Strachan S.T., Benner G.E., Sample A.K., Anderson Jr. G.W., Adamovicz J.J., et al. Protective efficacy of recombinant Yersinia outer proteins against bubonic plague caused by encapsulated and nonencapsulated Yersinia pestis. Infect Immun 67 3 (1999) 1533-1537
33. Rupprecht C.E., Hanlon C.A., and Slate D. Oral vaccination of wildlife against rabies: opportunities and challenges in prevention and control. Dev Biol (Basel) 119 (2004) 173-184
34. Mencher J.S., Smith S.R., Powell T.D., Stincomb D.T., Osorio J.E., and Rocke T.E. Protection of black-tailed prairie dogs (Cynomys ludovicianus) against plague after voluntary consumption of baits containing recombinant raccoon poxvirus vaccine. Infect Immun 72 9 (2004) 5502-5505